In clinical trials, people lost an average of 9.4% to 14.7% of their body weight over 40 weeks
Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction
While GLP-1 agonists offer a powerful option for those struggling with obesity or metabolic conditions, traditional approaches remain a viable solution for many
Ros stock price has increased up to 5 points over the past weekend since the launch of the campaign
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
The mechanism of action, slowing gastric emptying via GLP-1 receptor stimulation, is shared across the entire drug class